Sector: Pharmaceuticals & Biotechnology

Large Cap

Alkem Laboratories Share Price

Alkem Laboratories Ltd.

₹5,475

95.00(1.77%)

Invest in ALKEM with up to 4.00x margin.

Trade with MTF

27th May 2026 | 3:28 PM

NSE : ALKEM

Open Free Demat Account

Alkem Laboratories Performance

Price Movement

₹5475.00

₹5329.00

₹5521.50

↘ Today's Low↗ Today's High

1 Year Performance

₹5475.00

₹4716.20

₹5933.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹5,521.50

Low₹5,329.00

Open at₹5,414.50

Prev Close₹5,380.00

Volumes1.86 L

Avg Price₹5,412.44

Lower Circuit₹4,842.00

Upper Circuit₹5,918.00

Historical Performance

3M High₹5,781.50

3M Low₹5,075.00

1 Yr High₹5,933.50

1 Yr Low₹4,716.20

3 Yr High₹6,439.90

3 Yr Low₹3,307.20

5 Yr High₹6,439.90

5 Yr Low₹2,828.00

Alkem Laboratories Fundamentals

Market Cap

High in industry

65,180.90 Cr.

PE Ratio (TTM)

Above industry Median

27.50

Dividend Yield

Below industry Median

0.90

Net Profit TTM

10.1% incr over last year

2,371.20

Net Profit Growth

10.1% incr over last year

2,371.20

PEG Ratio

High in industry

2.70

ROE

3.7% incr over last year

18.06

Operating Revenue TTM

14,252.70

Operating Revenue Growth

11.7% incr over last year

Book Value

Above industry Median

4.70

MFI

MFI is mid-range

49.46

RSI

RSI is mid-range

49.62

EPS (TTM)

181.11

Debt to Equity

0.09

Face Value

Operating Profit Margin Qtr.

18.67

Operating Profit Qtr.

828

Net Profit Qtr.

636.02

Operating Revenue Qtr.

3,736.82

PB Ratio

4.70

Alkem Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	2,491.27	2,542.03	2,372.17	2,044.94	2,286.83
Operating Expense	1,802.06	1,771.35	1,751.69	1,748.15	1,629
Operating Profit	689.21	770.68	620.48	296.79	657.83
Depreciation	60.91	58.59	58.89	91.64	67.61
Interest	15.51	12.75	12.79	16.91	21
Tax	84.01	77.05	57.41	73.95	62.17
Net Profit	622.14	786.73	656.16	276.94	723.12

ALKEM Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹5,402 - ₹0

Target Price

₹5,980

Stop Loss

Target Date

16 Feb 27

Potential Returns

10.70 %

View Call ↗

Alkem Laboratories Technicals

Alkem Laboratories Ltd. EMA & SMA

₹5475.00

95.00 (1.77%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹5429.4

Day EMA10 ₹5446

Day EMA12 ₹5450.3

Day EMA20 ₹5456.9

Day EMA26 ₹5457.4

Day EMA50 ₹5464.9

Day EMA100 ₹5482.8

Day EMA200 ₹5450.2

Alkem Laboratories Support and Resistance

Resistance

First Resistance₹5539.00

Second Resistance₹5626.50

Third Resistance₹5731.50

Support

First Support₹5346.50

Second Support₹5241.50

Third Support₹5154.00

Technical Indicators

Day RSI49.62

Day MFI49.46

Day ADX13.45

Day Commodity Channel Index-40.00

William-64.39

Day MACD-7.09

Day MACD Signal Line5.03

Day ATR146.77

Day ROC125-4.36

Day ROC212.01

Alkem Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	55.7	55.1	53	51.2	51.2	51.2
FII	10.1	9.4	9.1	9.5	10	10.2
DII	18.1	19.4	21.8	21.9	21.5	21.3
Public	16.2	16	16	17.4	17.3	17.2

Alkem Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	22.5 K	64.32 K	34.98%
Week	25.7 K	65.49 K	39.25%
1 Month	40.2 K	88.72 K	45.31%
6 Month	69.47 K	1.2 L	58.06%

Alkem Laboratories SWOT Analysis

Strengths14

Weakness8

Opportunity3

Threats2

Positive Breakout First Resistance ( LTP > R1)

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Top Gainers

Volume Shockers

Alkem Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
20 Feb, 2026	43	INTERIM	20 Feb, 2026	Equity Share
08 Aug, 2025	8	FINAL	08 Aug, 2025	Equity Share
14 Feb, 2025	37	INTERIM	14 Feb, 2025	Equity Share
09 Aug, 2024	5	FINAL	10 Aug, 2024	Equity Share
16 Feb, 2024	35	INTERIM	17 Feb, 2024	Equity Share
10 Aug, 2023	10	FINAL	10 Aug, 2023	Equity Share
17 Feb, 2023	25	SPECIAL	18 Feb, 2023	Equity Share
17 Feb, 2023	15	INTERIM	18 Feb, 2023	Equity Share
08 Aug, 2022	4	FINAL	10 Aug, 2022	Equity Share
10 Feb, 2022	30	INTERIM	12 Feb, 2022	Equity Share

Alkem Laboratories Stock Comparison

Financials	Anthem Biosciences Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹756.50	₹1,132	₹1,782	₹1,724	₹2,428.40	₹174.50
% Change	-2.04%	-0.79%	-1.31%	1.50%	0.20%	-2.44%
Revenue TTM (₹ Cr)	₹2,124.33	₹2,192.49	₹1,421.59	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹591.79	₹348.91	₹-73.80	₹924.36	₹1,912.93	₹-325.93
PE TTM	72.10	68.80	-278.20	35.40	52.20	-71.10
1 Year Return	32.84	53.81	1.51	22.94	-0.41	-15.12
ROCE	27.56	18.38	0.59	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3005.00

-0.98%

GLAND

Gland Pharma Ltd.

₹ 2315.00

+0.31%

LAURUSLABS

Laurus Labs Ltd.

₹ 1381.10

+0.52%

BIOCON

Biocon Ltd.

₹ 433.75

-0.55%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6791.50

+0.57%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3025.00

-2.33%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1087.00

+0.74%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2383.40

+1.36%

WOCKPHARMA

Wockhardt Ltd.

₹ 1780.10

+4.70%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1431.90

-2.01%

NATCOPHARM

Natco Pharma Ltd.

₹ 1179.00

-0.59%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1840.00

-0.04%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 16750.00

-1.88%

IPCALAB

Ipca Laboratories Ltd.

₹ 1572.00

-0.38%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2200.00

+0.46%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8603.00

-4.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2300.00

+0.77%

PFIZER

Pfizer Ltd.

₹ 4619.90

-0.47%

ABBOTINDIA

Abbott India Ltd.

₹ 27700.00

+0.33%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4529.10

+1.73%

LUPIN

Lupin Ltd.

₹ 2275.00

+0.40%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1320.00

-0.59%

CIPLA

Cipla Ltd.

₹ 1422.00

+0.32%

FAQ's on ALKEM

What is the current share price of Alkem Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Alkem Laboratories Ltd. is ₹ 5475 on the NSE and ₹ 5479 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Alkem Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Alkem Laboratories Ltd. is approximately ₹ 65180.9 Cr.

What are the PE and PB ratios for Alkem Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Alkem Laboratories Ltd. is 27.5, and the Price-to-Book (PB) ratio is 4.7.

What is the 52-Week High and Low for Alkem Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Alkem Laboratories Ltd. shares was ₹ 5933.5, and the lowest price was ₹ 4716.2.

What is the current dividend yield for Alkem Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Alkem Laboratories Ltd. is 0.9%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Alkem Laboratories Ltd.?

Significant shareholdings in Alkem Laboratories Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Alkem Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Alkem Laboratories Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Alkem Laboratories Ltd.?

Alkem Laboratories Ltd. last declared a INTERIM dividend of ₹ 43 per share for the financial period ending 2026. The record date was set as 2026-02-20, and the payment was/is scheduled around 2026-02-20. For the most current dividend announcements, refer to official company filings.